Albemarle Reports First Quarter Sales Growth of 12%
News provided by
Share this article
Share this article
CHARLOTTE, N.C., May 5, 2021 /PRNewswire/ Albemarle Corporation (NYSE: ALB) today announced its results for the first quarter ended March 31, 2021.
First Quarter 2021 Highlights
(Unless otherwise stated, all percent changes are based on year-over-year comparisons)
Net income of $95.7 million, or $0.84 per diluted share; Adjusted diluted EPS of $1.10, an increase of 10%
Net sales of $829.3 million, an increase of 12%
Adjusted EBITDA of $230.1 million an increase of 17%
Full year 2021 guidance unchanged
Entered into a definitive agreement to sell the Fine Chemistry Services business to W. R. Grace & Co. for proceeds of approximately $570 million
W R Grace to be acquired in $4 6 billion deal
baltimoresun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from baltimoresun.com Daily Mail and Mail on Sunday newspapers.
WR Grace to be acquired in $4 6 billion deal
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
Plant Watch: Business News for April 2021
MaxxDrive industrial gear units provide high output torque from 132,000…
By Mary Page Bailey |
Thermo Fisher Scientific plans $600-million bioprocessing expansion
March 12, 2021 Thermo Fisher Scientific Inc. (Waltham, Mass.; www.thermofisher.com) plans to invest more than $600 million in capital investments to expand its bioprocessing production capabilities through 2022. These investments are expected to more than double the company’s current manufacturing capacity. Highlights of the investment include capacity expansions at several sites in the U.S., China, Scotland and Singapore. Furthermore, the company will open a new resin-manufacturing facility in Chelmsford, Mass.
Hexion to expand Portland manufacturing plant